Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
13.34 USD | +0.08% | +2.39% | -38.33% |
03:14pm | Oppenheimer Cuts Teladoc's Price Target to $21 From $26, Maintains Outperform Rating | MT |
Apr. 25 | Transcript : Teladoc Health, Inc., Q1 2024 Earnings Call, Apr 25, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-38.33% | 2.26B | |
+22.24% | 520M | |
+42.77% | 467M | |
-63.74% | 160M | |
-31.65% | 87.05M |
- Stock Market
- Equities
- TDOC Stock
- News Teladoc Health, Inc.
- Teladoc Health : Cowen Adjusts Teladoc's Price Target to $188 From $240, Keeps Outperform Rating